Bastola and colleagues demonstrated that CSCs were enriched at tumor edge compared to tumor core sites of GBM tissues and that the cells at core sites released soluble CD109 to induce CSCs at tumor edge to proliferate and to display radioresistance [171]. The gene discussed is CD109; the disease is glioblastoma.